Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Heva Health vs LillyDirect Foundayo

Heva Health
Graded #119

Higher grade

vs+2.5
LillyDirect Foundayo
Graded #173

Lower grade

The verdict

Heva Health takes it — 69.7/100 to 67.2/100.

Heva Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Heva Health (hevahealth.com) is a LegitScript-certified concierge telehealth platform offering compounded GLP-1s with a 91-biomarker comprehensive lab panel, hormone optimization (HRT/TRT), and concierge care.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHeva Health +2
74
72
Dose & formulationLillyDirect Foundayo +7
52
59
Clinical oversightLillyDirect Foundayo +4
74
78
Labs & monitoringHeva Health +37
89
52
FulfillmentLillyDirect Foundayo +11
69
80
Contract termsEven
55
55
Heva Health · left barLillyDirect Foundayo · right bar

The numbers

MetricHeva HealthLillyDirect Foundayo
WeighScore69.7/10067.2/100
GradeCC
Scorecard rank#119#173
Semaglutide$149/mo (compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Heva Health

Graded #119 · C

Strengths

  • $149/mo entry pricing for compounded GLP-1 is competitive
  • LegitScript Certified
  • Claims licensure in all 50 states
  • Comprehensive 91-biomarker lab panel bundled — a differentiator vs compounded-GLP-1-only peers
  • Concierge care plus HRT/TRT alongside GLP-1 for an integrated longevity stack

Where it loses points

  • Tirzepatide pricing not shown — only the generic $149/mo weight-loss entry
  • Legal entity name and state of incorporation not disclosed
  • Partner pharmacy not named
  • Per-state availability not listed despite the all-50-states claim
  • Brand-name GLP-1 options (Wegovy/Zepbound/Mounjaro/Ozempic/Foundayo) not addressed
LillyDirect Foundayo

Graded #173 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard